首页 | 本学科首页   官方微博 | 高级检索  
检索        

西妥昔单抗联合化疗在治疗大肠癌肝转移中的疗效观察
引用本文:王凤云,张艳桥,张纯惠,燕飞虎,李志伟,张倩倩.西妥昔单抗联合化疗在治疗大肠癌肝转移中的疗效观察[J].哈尔滨医科大学学报,2010,44(1).
作者姓名:王凤云  张艳桥  张纯惠  燕飞虎  李志伟  张倩倩
作者单位:哈尔滨医科大学第三临床医学院,消化内科,黑龙江,哈尔滨,150081
摘    要:目的观察西妥昔单抗联合化疗在治疗大肠癌肝转移中的疗效。方法8例失去手术机会或不愿手术的大肠癌肝转移患者,应用西妥昔单抗(cetuxim ab)联合化疗,以治疗后肝脏CT、肿瘤标记物评价疗效。结果8例全部按计划完成治疗,西妥昔单抗联合化疗近期有效率为62%,肝转移灶有不同程度的缩小或消失,其中肝转移灶完全消失(CR)1例,缩小(PR)6例,稳定(SD)1例,增大(PD)0例,所有病例肿瘤标记物均有不同程度下降。结论西妥昔单抗联合化疗能提高大肠癌肝转移化疗的疗效。

关 键 词:西妥昔单抗  大肠癌肝转移  化疗  

Effect of cetuximab combined with chemotherapy in liver metastasis of colorectal carcinoma
WANG Feng-yun,ZHANG Yan-qiao,ZHANG Chun-hui,et al.Effect of cetuximab combined with chemotherapy in liver metastasis of colorectal carcinoma[J].Journal of Harbin Medical University,2010,44(1).
Authors:WANG Feng-yun  ZHANG Yan-qiao  ZHANG Chun-hui  
Institution:Department of Gastroenterology;The Third Clinical College;Harbin Medicine University;Harbin 150081;China
Abstract:Objective To observe the effect of cetuximab combined with chemotherapy in liver metastasis of colorectal carcinoma.Methods Eight patients with liver metastasis of colorectal carcinoma,who lost the opportunity of operation or not willing to operate,treated by cetuximab combined with chemotherapy.Therapeutic effect was evaluated with liver CT and tumor marker.Results Eight patients all underwent therapy as planned.The efficacy in the near future was 62%.Liver metastasis decreased or disappeared in different ...
Keywords:cetuximab  liver metastasis of colorectal carcinoma  chemotherapy  
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号